News

People in Profile: Logan Trenaman

Meet Logan – researcher, returning recreational hockey player, and facilitator of better health care decision-making.

+
CADTH’s 25th Anniversary Lecture Series – Dr. Stirling Bryan

As part of CADTH’s 25th anniversary celebrations, we’ve launched a special lecture series on health technology assessment (HTA) in Canada.

We invite you to join us for the next talk in our series, featuring Dr. Stirling Bryan, Director, Centre for Clinical Epidemiology and Evaluation, The University of British Columbia. Dr. Bryan will argue that “It’s Time to Break Our Addiction to Technology Adoption: Reframing HTA as the Cornerstone of ‘Resource Stewardship’.”

+
Online videos in six languages help immigrant patients breathe better

Resources developed through dedicated community-based participatory approach.

+
Dr. Nick Bansback receives a CIHR New Investigator Award

Dr. Nick Bansback Receives CIHR New Investigator Award

+
Lidia Engel – Award recipient for the best student oral presentation at the HTAi meeting 2014

Lidia Engel, PhD student at SFU and research assistant at C2E2, presented work on ‘Examining Exclusion Criteria in National Health State Valuation Studies: a Systematic Review’ and received an award for the best student oral presentation.

+
New health technologies: an addiction that needs to be broken

Slowing the rapid growth of health care spending requires a shift in focus away from adopting new technologies (i.e. drugs, devices, procedures, and screenings) toward better management of already existing technologies, according to an editorial authored by researchers at the Centre for Clinical Epidemiology and Evaluation (C2E2), a major research centre within Vancouver Coastal Health Research Institute.

+
C2E2 Annual Lecture - video and photos now available

 

Videos of all our Annual Lectures are available at this YouTube link

+
Low adherence to controller medications and the preventable burden of asthma

Low adherence to controller therapies is an important contributor to the fact that asthma remains uncontrolled in a large proportion of patients—despite the fact that for most patients, effective and inexpensive controller therapies are readily available.

+

Pages